Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.18 -1.26 (-2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Depreciation and Depletion (2010 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) recorded Depreciation and Depletion of $9.6 million in Q2 2026, down 9.4% from $10.6 million a year earlier but up 9.1% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Depreciation and Depletion (2010 - 2026) Analysis & Trends

On a TTM basis, Biomarin Pharmaceutical's Depreciation and Depletion came in at $42.2 million as of Jun 30, 2026, down 10.6% year-over-year; for FY2025, it was $48.5 million, up 4.1% from FY2024.

  • Annual Depreciation and Depletion has increased for three straight years, with a five-year compound annual growth rate of 2.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation and Depletion came in at $46.6 million in FY2024 (+15.6%), $40.3 million in FY2023 (+4.4%), $38.6 million in FY2022 (-16.3%) and $46.1 million in FY2021 (+7.2%).
  • Quarterly Depreciation and Depletion has ranged from $8.7 million in Q3 2022 to $14.1 million in Q1 2025 over the past five years.
  • On a year-over-year basis, Depreciation and Depletion rose in four of the last eight quarters, with an average decline of 1.7%.
  • Peak year-over-year performance for Depreciation and Depletion in the last five years was growth of 23.0% in Q4 2023, against a decline of 37.6% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.8 million (Q1 2026), $13.2 million (Q4 2025) and $10.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biomarin Pharmaceutical 11.07 Bn 4.93 Bn 786.91 Mn 9.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.60 Mn
Mar 31, 2026 8.80 Mn
Dec 31, 2025 13.20 Mn
Sep 30, 2025 10.60 Mn
Jun 30, 2025 10.60 Mn
Mar 31, 2025 14.10 Mn
Dec 31, 2024 11.60 Mn
Sep 30, 2024 10.90 Mn
Jun 30, 2024 11.50 Mn
Mar 31, 2024 12.60 Mn
Dec 31, 2023 10.70 Mn
Sep 30, 2023 9.90 Mn
Jun 30, 2023 9.40 Mn
Mar 31, 2023 10.30 Mn
Dec 31, 2022 8.70 Mn
Sep 30, 2022 8.70 Mn
Jun 30, 2022 9.50 Mn
Mar 31, 2022 11.70 Mn
Dec 31, 2021 10.40 Mn
Sep 30, 2021 11.40 Mn
API Access

Biomarin Pharmaceutical Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=BMRN&period=max&api_key=YOUR_API_KEY